This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Daniel Gm Shore
Introduction
Daniel Gm Shore is an accomplished inventor based in Redwood City, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of JAK kinase inhibitors. His work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Daniel Gm Shore holds a patent for "Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof." This patent describes compounds and salts that are useful as JAK kinase inhibitors. It also includes pharmaceutical compositions that incorporate such a JAK inhibitor along with a pharmaceutically acceptable carrier, adjuvant, or vehicle. The methods outlined in the patent aim to treat or lessen the severity of diseases responsive to the inhibition of Janus kinase activity in patients. He has 1 patent to his name.
Career Highlights
Daniel is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include Marian C Bryan and Yun-Xing Cheng. Their collaborative efforts have likely played a role in advancing the research and development of JAK kinase inhibitors.
Conclusion
Daniel Gm Shore's innovative work in the field of JAK kinase inhibitors showcases his dedication to improving patient outcomes through scientific advancements. His contributions are a testament to the importance of research and collaboration in the pharmaceutical industry.